Warning: include(phj2-admin/kernel/config.php): failed to open stream: No such file or directory in /zstorage3/vhosts/fz.kiev.ua/httpdocs/index.php on line 45

Warning: include(): Failed opening 'phj2-admin/kernel/config.php' for inclusion (include_path='.:/usr/local/share/pear') in /zstorage3/vhosts/fz.kiev.ua/httpdocs/index.php on line 45

Warning: Cannot modify header information - headers already sent by (output started at /zstorage3/vhosts/fz.kiev.ua/httpdocs/index.php:45) in /zstorage3/vhosts/fz.kiev.ua/httpdocs/kernel/content.php on line 3

Warning: array_unique() expects parameter 1 to be array, null given in /zstorage3/vhosts/fz.kiev.ua/httpdocs/kernel/content.php on line 77

Warning: Invalid argument supplied for foreach() in /zstorage3/vhosts/fz.kiev.ua/httpdocs/kernel/content.php on line 86
Fiziologichnyi Zhurnal - <a id="lj1_ret_bk_to_jl0_href_id" href="?list0=19">Fiziol. Zh. 2017;</a> <a id="lj1_ret_bk_to_jl0_href_id" href="?list1=99">63(2):</a> 34-39
Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2017; 63(2): 34-39


MORPHOFUNCTIONAL STATE OF MAST CELLS IN HYPERHEPARINEMIA IN RATS

S. Kotiuzhynska, A. Gozhenko, D. Umanskyi

    Odessa National Medical University
DOI: https://doi.org/10.15407/fz63.02.034

Abstract

A clear relationship between the functional state of mast cells and the heparin level in plasma in experimental hyperlipidemia in rats has been revealed. It was shown that long-term lipid load increases the activity and number of secretory mast cells. We show the ability of mast cells to deposit the excess of heparin when it is in the organism, that is evidenced by an increase in the number of cells with high saturation level (59,16±3,42% vs 33,54±3,27%) with the simultaneous decline in the number of cells with moderate saturation level (by 40,63 %) with the simultaneous increase of saturation index. Relative to control group.

Keywords: mast cells, heparin, experimental hyperlipidemia.

References

  1. Ilyin DA. Relevant aspects of the study of mast cells in vitro. Mod World, Nat Peop: Coll Sci. Work. Tomsk,2011; 2 (1): 74-7.
  2.  
  3. Kryzhanovsky GN. Fundamental research in the systemof medico-biological sciences. Herald Rus Acad MedSci. 2006; 3: 31-3.
  4.  
  5. Bykov VL. Development and heterogeneity of mast cells. Morphology 2010; 127(2): 86-92.
  6.  
  7. Gafarova RK. Reaction of mast cells on ischemia. MedImmunol. 2009; 11(4-5): 306-7.
  8.  
  9. Santos EA., Rocha LR., Pereira NM. et al. Mast cells arepresent in epithelial layers of different tissues of the molluscAnomalocardia brasiliana. In situ characterizationof heparin and a correlation of heparin and histamineconcentration Histochem J. 2013; 44: 553-8.
  10.  
  11. Artashyan OS. Yushkov B G., Khramtsova YS. The morphologicalaspects of involvement of mast cells in theformation of General adaptation syndrome. Taurid MedBiol Bull. 2012; 15(3): 22-8.
  12.  
  13. Gavrisheva HA. Fat cells of the heart in norm and at apathology: a review. Cardiology. 2015; 55(6): 59-65.
  14.  
  15. Sun J., Sukhova GK., Wolters PJ. Mast cells promoteatherosclerosis by releasing proinflammatory cytokines. Nat Med. 2015; 19: 719-24.
  16.  
  17. Kondashevskaya MV. Mast cells and heparin - key linksin adaptive and pathological processes. Bull Rus Acad Med Sci. 2010; 6: 49-54.
  18.  
  19. Kotyuzhinskaya S. Functional status of mast cells withexperimental hypoheparinemia. Pharm Innovat J. 2014; 3(4): 67-71.
  20.  
  21. Kim LB, Kulikov YuV, Melnikov VN Role of heparinin the regulation of transcapillary exchange and lipidperoxidation in patients with coronary heart disease. BullSiber Branch Acad Med Sci. 2010; 1: 72-7.
  22.  
  23. Kotiuzhynska SG., Gozhenko AI. Heparin: regulationof hemostasis and megamastoides. Circul Hemostas. 2006; 2: 11-7.
  24.  
  25. He SH. Key role of mast cells and their major secretoryproducts in inflammatory bowel disease. Wold J Gastroenterol. 2014; 10: 309-18
  26.  
  27. Khalil M., Ronda J., Weintraub M. et al. Brain mast cellrelationship to neurovasculature during development. Brain Res 2014; 26(1171): 18-29.
  28.  
  29. Kordenko AN, Alekseeva NT., Anokhina JA. Specificfeatures of the structure of the fat cells of the skin. J. Anatom Histopathol. 2014; 3 (4): 36-8.
  30.  
  31. Yushkov BG., Chereshnev VA., Klimin VG., Artesian OS.Mast cells. Physiology and pathophysiology. Moscow:Medicine, 2011.
  32.  
  33. Ryzhov EV., Makarov VG. Methodical instructions tostudy the hypolipidemic and antiatherosclerotic action of pharmacological substances. Manual on experimental(preclinical) study of pharmacological substances: editedby RY. Khabrieva. – Moscow: Med, 2005.
  34.  
  35. Ulyanov AM., Tarasov YuA. Insular system of animalsin chronic defi zite heparin. Probl Med Chem. 2000; 46(2): 149-54.
  36.  
  37. Berkovsky AL., Sergeyeva EV., Suvorov AV., KozlovAA. Methods for determining the activity of heparin –Moscow: Print, 2013.
  38.  
  39. Sarkisov DS. Perov YuI. Microscopic technique . Moscow:Med, 1996.
  40.  
  41. Linder DP., Poberii IA., Roskin MJ. Morphometricanalysis of populations of mast cells. Arch Pathol. 1980; 6: 21-3.
  42.  
  43. Kotiuzhynska SG. Lipoproteiin lipase activity lipidtransportsystem at hyperheparinemia. Med Chem. 2014; 16 (1): 17-20.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.